Rousselot, Darling Ingredients’ health brand, and the global leader of collagen-based solutions1, has announced that the European Patent Office (EPO) has granted the company’s patent application for its SiMoGel solution – a gelatine-based solution for functional gummies.
Launched in 2018, SiMoGel enables the production of nutraceutical gummies using a starch-free process – providing the hygienic conditions needed for supplements. The gelatine-based solution not only helps optimise the production process of nutraceutical gummies, but also enables producers to bring tasty, innovative and competitive delivery forms to the market.
“We’re delighted to have achieved this important step in protecting our innovative SiMoGel solution,” said Marit van der Heijden, global marketing and project manager at Rousselot. “The patent grant by the EPO strengthens our current patent portfolio and confirms that we are delivering truly innovative solutions to the market. In securing this patent, we are able to offer our customers even more opportunities for secure product development, allowing them to tap into the growing nutraceutical gummy market.”
Over the past few years, nutraceutical gummies have proven to be a popular delivery form achieving a CAGR of 37.3% from 2016 to 20202. As the market continues to expand, so too do the opportunities. To further improve gummies as a delivery form, Rousselot recently launched a new SiMoGel-based process solution, which enables the production of centre-filled nutraceutical gummies; known also as gummy caps. This unique concept combines the benefits of soft gels and gummies in a single delivery form – making it the first of its kind to be launched on the nutraceutical and pharmaceutical markets.
der Heijden, concluded: “We are committed to using gelatine as the preferred excipient in this application, as we believe its many functional benefits and natural origins bring endless possibilities for consumers to enjoy their daily vitamins, and even medicines. Rousselot’s team is looking forward to applying the SiMoGel concept in collaboration with our customers to create innovative products, such as 3D gummies, coming with visually appealing and palatable shapes. Our teams of food and nutrition experts are particularly eager to provide formulation support and help nutra- and pharmaceutical players reach their new product development goals.”
The patent granted by the EPO (ref. EP3570680B1) is effective in all major countries in Europe and is pending in Brazil, Japan and the United States.
1 Global Gelatin Market Insights Forecast to 2026, Calibre Research, 2020
2 Innova Market Insights